Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC KG5 | 877874-85-6 | C20H16F3N7OS | 50 MG
SDP

Catalog No. 5000373421
Encompass_Preferred

KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor, also inhibiting Flt3, KIT, and c-Raf. It demonstrates anticancer and antiangiogenic activities, preventing tumor growth and blocking angiogenesis in various models.

  • Inhibits vascular smooth muscle cells (VSMCs) and endothelial cell viability
  • Selectively blocks S338 phosphorylation
  • Inhibits PDGFRα and β, Flt3, and KIT
  • Inhibits phosphorylation of MEK and ERK in endothelial cells
  • Prevents tumor growth in an orthotopic renal cell carcinoma model
  • Completely blocks angiogenesis in mice

Catalog No. 50-003-73421 Supplier Medchemexpress LLC Supplier No. HY1519850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor, also inhibiting Flt3, KIT, and c-Raf. It demonstrates anticancer and antiangiogenic activities, preventing tumor growth and blocking angiogenesis in various models.

  • Inhibits vascular smooth muscle cells (VSMCs) and endothelial cell viability
  • Selectively blocks S338 phosphorylation
  • Inhibits PDGFRα and β, Flt3, and KIT
  • Inhibits phosphorylation of MEK and ERK in endothelial cells
  • Prevents tumor growth in an orthotopic renal cell carcinoma model
  • Completely blocks angiogenesis in mice

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.